1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Chr. Hansen Holding A/S
  6. Summary
    CHR   DK0060227585

CHR. HANSEN HOLDING A/S

(CHR)
  Report
Delayed Nasdaq Copenhagen  -  10:59 2022-07-05 am EDT
535.00 DKK   +1.02%
04/25Lillie Li Valeur steps down from the Board of Directors
GL
04/25Lillie Li Valeur steps down from the Board of Directors
GL
04/25Chr. Hansen Announces Lillie Li Valeur Steps Down from the Board of Directors
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
06/29/2022 06/30/2022 07/01/2022 07/04/2022 07/05/2022 Date
523(c) 516.6(c) 525.4(c) 529.6(c) 535(c) Last
176 722 195 955 157 458 130 783 252 907 Volume
-0.11% -1.22% +1.70% +0.80% +1.02% Change
More quotes
Estimated financial data (e)
Sales 2022 1 212 M 1 242 M 1 242 M
Net income 2022 231 M 237 M 237 M
Net Debt 2022 888 M 910 M 910 M
P/E ratio 2022 41,0x
Yield 2022 1,32%
Sales 2023 1 315 M 1 347 M 1 347 M
Net income 2023 264 M 271 M 271 M
Net Debt 2023 854 M 875 M 875 M
P/E ratio 2023 35,9x
Yield 2023 1,47%
Capitalization 9 467 M 9 699 M 9 699 M
EV / Sales 2022 8,54x
EV / Sales 2023 7,85x
Nbr of Employees 3 702
Free-Float 77,8%
More Financials
Company
Chr. Hansen Holding A/S specializes in the development, production and marketing of biotechnological ingredients for the food processing, animal feed and health industries. Net sales (excluding activities being sold) break down by family of products as follows: - cultivations and enzymes (65%); - medical and nutritional ingredients (35%): used in the manufacturing of dietary supplements, OTC drugs, baby products... 
Sector
Food Processing
Calendar
07/07 | 02:00amEarnings Release
More about the company
Ratings of Chr. Hansen Holding A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about CHR. HANSEN HOLDING A/S
04/25Lillie Li Valeur steps down from the Board of Directors
GL
04/25Lillie Li Valeur steps down from the Board of Directors
GL
04/25Chr. Hansen Announces Lillie Li Valeur Steps Down from the Board of Directors
CI
04/20Chr. Hansen introduces new VEGA(TM) SAFEPRO® culture range for plant-based meat alterna..
AQ
04/20CHR HANSEN A/S : . Hansen introduces new VEGA™ SAFEPRO® culture range for plant-base..
PU
04/11CHR HANSEN A/S : New HMO study paves the way for developing next-generation infant formula
PU
04/11PROBIOTIC JUICES : a fresh take on a classic beverage enjoyed at every stage of life
PU
04/08CHR HANSEN A/S : Q2 Conference call transcript 2021/22
PU
04/06Chr. Hansen Holding A/S Reports Earnings Results for the Second Quarter and Six Months ..
CI
04/06TRANSCRIPT : Chr. Hansen Holding A/S, Q2 2022 Earnings Call, Apr 06, 2022
CI
04/06CHR HANSEN A/S : Q2 Roadshow presentation 2021/22
PU
04/06CHR HANSEN A/S : . Hansen reports strong organic growth of 14% for Q2 in a challenging env..
PU
04/06Chr. Hansen Holding A/S Interim Report Q2 2021/22
GL
04/06Chr. Hansen Holding A/S Provides Earnings Guidance for the Year 2022
CI
04/06CHR. HANSEN HOLDING A/S : Half-year results
CO
More news
News in other languages on CHR. HANSEN HOLDING A/S
04/25Chr. Hansen annonce que Lillie Li Valeur se retire du conseil d'administration
04/06Chr. Hansen Holding A/S annonce ses résultats pour le deuxième trimestre et le semestre..
04/06Dura Lex, Fed Lex
04/06EN DIRECT DES MARCHES : Saint-Gobain, EDF, Air France-KLM, GTT, Volkswagen, JetBlue, Intel..
04/06Chr. Hansen Holding A/S fournit des prévisions de bénéfices pour l'année 2022
More news
Analyst Recommendations on CHR. HANSEN HOLDING A/S
More recommendations
Chart CHR. HANSEN HOLDING A/S
Duration : Period :
Chr. Hansen Holding A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHR. HANSEN HOLDING A/S
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 71,90 €
Average target price 72,82 €
Spread / Average Target 1,28%
EPS Revisions
Managers and Directors
Mauricio Graber President & Chief Executive Officer
Lise Skaarup Mortensen Chief Financial Officer & Executive Vice President
Dominique Reiniche Chairman
Henrik Joerck Nielsen Chief Scientific Officer & Executive VP
Torsten Steenholt Executive Vice President-Global Operations